-
-
-
Taoguanhong, deputy director of the Management Committee of the high tech Zone, and his delegation inspected anku biology
On the afternoon of February 26, 2021, taoguanhong, deputy director of the administrative committee of Suzhou high tech Zone and deputy head of Huqiu District government
-
Discovery of the target of redcivir by core technology of anku biology
In October 2020, the U.S. Food and Drug Administration (FDA) approved the antiviral drug remdesivir of Gilead science for the treatment of hospitalized patients with covid-19, becoming the first officially approved covid-19 in the United States. However, due to the strong hepatorenal toxicity, the clinical dose of redcivir has been strictly limited.
-
Angalbio's parent company was successfully selected into the
On May 12, 2020, the EU innovative drugs initiative announced the list of covid-19 emergency projects with a total amount of 72million euros, and Austria JLP health, the parent company of anku Biotechnology (Suzhou) Co., Ltd., was successfully selected.
-
Anku biology, a major project company of the Provincial Institute of industry and research for the treatment of severe novel coronavirus infection, assisted IIT clinical research
A few days ago, the Austrian biotechnology company apeiron biology announced the launch of an investigator initiated clinical trial
-
Ma Qiulin, vice governor of Jiangsu Province, led a team to inspect the Austrian headquarters of anku Biotechnology (Suzhou) Co., Ltd
Recently, Ma Qiulin, vice governor of Jiangsu Province, led a team, together with the Provincial Department of science and technology, the Provincial Department of industry and information technology, the provincial SASAC
-
Anku Biotechnology (Suzhou) Co., Ltd. is based on the high level of the world
Anku Biotechnology (Suzhou) Co., Ltd. has grandly launched a new generation of pharmaceutical products in Suzhou Based on the world's high-level technology.
-
Austrian anku biological project settled in Suzhou high tech Zone
Suzhou life and health town welcomes the heavyweight project again. On February 21, Suzhou Baimajian life health town construction and Development Co., Ltd., Austria anku biological JLP health Co., Ltd. and Jiangsu Industrial Technology Research Institute officially signed a cooperation agreement to invest in the construction of anku biological project in Suzhou life health town and build a world-class biomedical technology application platform.